Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 1036 AL 1050

Serine phosphorylation and arginine methylation at the crossroads to neurodegeneration

Basso M, Pennuto M.

Exp Neurol. 2015 Sep;271:77-83. doi: 10.1016/j.expneurol.2015.05.003. Epub 2015 May 12.

HECT-type E3 ubiquitin ligases in nerve cell development and synapse physiology

Ambrozkiewicz MC, Kawabe H.

FEBS Lett. 2015 Jun 22;589(14):1635-43. doi: 10.1016/j.febslet.2015.05.009. Epub 2015 May 13.

Comorbidities in Neurology: Is adenosine the common link?

Boison D, Aronica E.

Neuropharmacology. 2015 Oct;97:18-34. doi: 10.1016/j.neuropharm.2015.04.031. Epub 2015 May 13.

Approach to the patient with Parkinson disease

Johnson KE.

Prim Care. 2015 Jun;42(2):205-15. doi: 10.1016/j.pop.2015.01.005. Epub 2015 Mar 5.

Biomarkers in Parkinson disease: It's time to combine

McKeown MJ, Peavy GM.

Neurology. 2015 Jun 16;84(24):2392-3. doi: 10.1212/WNL.0000000000001692. Epub 2015 May 15.

Splicing: is there an alternative contribution to Parkinson's disease?

La Cognata V, D'Agata V, Cavalcanti F, Cavallaro S.

Neurogenetics. 2015 Oct;16(4):245-63. doi: 10.1007/s10048-015-0449-x. Epub 2015 May 16.

Levodopa alone compared with levodopa-sparing therapy as initial treatment for Parkinson's disease: a meta-analysis

Xie CL, Zhang YY, Wang XD, Chen J, Chen YH, Pa JL, Lin SY, Lin HZ, Wang WW.

Neurol Sci. 2015 Aug;36(8):1319-29. doi: 10.1007/s10072-015-2253-7. Epub 2015 May 17.

Non-motor symptoms burden in treated and untreated early Parkinson's disease patients: argument for non-motor subtypes

Zis P, Martinez-Martin P, Sauerbier A, Rizos A, Sharma JC, Worth PF, Sophia R, Silverdale M, Chaudhuri KR.

Eur J Neurol. 2015 Aug;22(8):1145-50. doi: 10.1111/ene.12733. Epub 2015 May 15.

Manganese homeostasis in the nervous system

Chen P, Chakraborty S, Mukhopadhyay S, Lee E, Paoliello MM, Bowman AB, Aschner M.

J Neurochem. 2015 Aug;134(4):601-10. doi: 10.1111/jnc.13170. Epub 2015 Jun 16.

[Neurodegenerative diseases 2014-2019: A plan without perineum]

Gamé X.

Prog Urol. 2015 Jun;25(8):435-6. doi: 10.1016/j.purol.2015.03.009. Epub 2015 May 14.

Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative

Laurens B, Constantinescu R, Freeman R, Gerhard A, Jellinger K, Jeromin A, Krismer F, Mollenhauer B, Schlossmacher MG, Shaw LM, Verbeek MM, Wenning GK, Winge K, Zhang J, Meissner WG.

Neurobiol Dis. 2015 Aug;80:29-41. doi: 10.1016/j.nbd.2015.05.004. Epub 2015 May 15.

Utility of the Japanese version of the 9-item Wearing-off Questionnaire

Fukae J, Higuchi MA, Yanamoto S, Fukuhara K, Tsugawa J, Ouma S, Hatano T, Yoritaka A, Okuma Y, Kashihara K, Hattori N, Tsuboi Y.

Clin Neurol Neurosurg. 2015 Jul;134:110-5. doi: 10.1016/j.clineuro.2015.04.021. Epub 2015 May 5.

Mechanisms of alpha-synuclein action on neurotransmission: cell-autonomous and non-cell autonomous role

Emanuele M, Chieregatti E.

Biomolecules. 2015 May 13;5(2):865-92. doi: 10.3390/biom5020865.

Development and initial validation of a Parkinson's disease caregiver strain risk screen

Abendroth M.

J Nurs Meas. 2015;23(1):4-21. doi: 10.1891/1061-3749.23.1.4.

Melatonin redox activity. Its potential clinical applications in neurodegenerative disorders

Miller E, Morel A, Saso L, Saluk J.

Curr Top Med Chem. 2015;15(2):163-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias